These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29278709)

  • 1. Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: A European analysis of over 60 million glucose tests.
    Dunn TC; Xu Y; Hayter G; Ajjan RA
    Diabetes Res Clin Pract; 2018 Mar; 137():37-46. PubMed ID: 29278709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world flash glucose monitoring in Brazil: can sensors make a difference in diabetes management in developing countries?
    Calliari LEP; Krakauer M; Vianna AGD; Ram Y; Barbieri DE; Xu Y; Dunn TC
    Diabetol Metab Syndr; 2020; 12():3. PubMed ID: 31921360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flash Glucose Monitoring in the Netherlands: Increased monitoring frequency is associated with improvement of glycemic parameters.
    Lameijer A; Lommerde N; Dunn TC; Fokkert MJ; Edens MA; Kao K; Xu Y; Gans ROB; Bilo HJG; van Dijk PR
    Diabetes Res Clin Pract; 2021 Jul; 177():108897. PubMed ID: 34098059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain.
    Gomez-Peralta F; Dunn T; Landuyt K; Xu Y; Merino-Torres JF
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32198165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme.
    Yeoh E; Png D; Koh PL; Sum CF; Lim SC; Tan HH; Ubeynarayana CU; Subramaniam T
    Diabet Med; 2022 Jan; 39(1):e14733. PubMed ID: 34698420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flash Glucose Monitoring in Israel: Understanding Real-World Associations between Self-Monitoring Frequency and Metrics of Glycemic Control.
    Eldor R; Roitman E; Merzon E; Toledano Y; Alves C; Tsur A
    Endocr Pract; 2022 May; 28(5):472-478. PubMed ID: 35167952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.
    Furler J; O'Neal D; Speight J; Blackberry I; Manski-Nankervis JA; Thuraisingam S; de La Rue K; Ginnivan L; Doyle R; Holmes-Truscott E; Khunti K; Dalziel K; Chiang J; Audehm R; Kennedy M; Clark M; Jenkins A; Lake AJ; Januszewski AS; Catchpool M; Liew D; Clarke P; Best J
    Lancet Diabetes Endocrinol; 2020 Jan; 8(1):17-26. PubMed ID: 31862147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real world hypoglycaemia related to glucose variability and Flash glucose scan frequency assessed from global FreeStyle Libre data.
    Riveline JP; Wojtusciszyn A; Guerci B; Alves C; Kao K; Xu Y; Dunn TC
    Diabetes Obes Metab; 2022 Nov; 24(11):2102-2107. PubMed ID: 35695037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flash glucose monitoring: Impact on markers of glycaemic control and patient-reported outcomes in individuals with type 1 diabetes mellitus in the real-world setting.
    Nana M; Moore SL; Ang E; Lee ZX; Bondugulapati LNR
    Diabetes Res Clin Pract; 2019 Nov; 157():107893. PubMed ID: 31669628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial.
    Tumminia A; Crimi S; Sciacca L; Buscema M; Frittitta L; Squatrito S; Vigneri R; Tomaselli L
    Diabetes Metab Res Rev; 2015 Jan; 31(1):61-8. PubMed ID: 24816997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the effect of the COVID-19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring.
    Dover AR; Ritchie SA; McKnight JA; Strachan MWJ; Zammitt NN; Wake DJ; Forbes S; Stimson RH; Gibb FW
    Diabet Med; 2021 Jan; 38(1):e14374. PubMed ID: 32740984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes.
    Deiss D; Hartmann R; Schmidt J; Kordonouri O
    Exp Clin Endocrinol Diabetes; 2006 Feb; 114(2):63-7. PubMed ID: 16570235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittently Scanned Continuous Glucose Monitoring Data of Polish Patients from Real-Life Conditions: More Scanning and Better Glycemic Control Compared to Worldwide Data.
    Hohendorff J; Gumprecht J; Mysliwiec M; Zozulinska-Ziolkiewicz D; Malecki MT
    Diabetes Technol Ther; 2021 Aug; 23(8):577-585. PubMed ID: 33794101
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous glucose monitoring: a review of the evidence, opportunities for future use and ongoing challenges.
    Wood A; O'Neal D; Furler J; Ekinci EI
    Intern Med J; 2018 May; 48(5):499-508. PubMed ID: 29464891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of continuous glucose monitoring system (CGMS) in monitoring glycaemic profile in small children with diabetes type 1].
    Głowińska-Olszewska B; Urban M; Peczyńska J; Florys B; Kowalewski M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(4):237-43. PubMed ID: 16232362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost calculation for a flash glucose monitoring system for UK adults with type 1 diabetes mellitus receiving intensive insulin treatment.
    Hellmund R; Weitgasser R; Blissett D
    Diabetes Res Clin Pract; 2018 Apr; 138():193-200. PubMed ID: 29410149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
    Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes.
    Bonora B; Maran A; Ciciliot S; Avogaro A; Fadini GP
    J Endocrinol Invest; 2016 Dec; 39(12):1391-1399. PubMed ID: 27287421
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.